Literature DB >> 10146878

Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?

W K Fant1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 10146878     DOI： 10.2165/00019053-199303060-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  48 in total

1.  The Clinton health care plan.

Authors:  B Clinton
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

2.  Impact of new technologies on health-care costs and on the nation's "health".

Authors:  T A Massaro
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

3.  Anti-endotoxin monoclonal antibodies.

Authors:  H S Warren; R L Danner; R S Munford
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

4.  Cost-effectiveness analysis: is it ethical?

Authors:  A Williams
Journal:  J Med Ethics       Date:  1992-03       Impact factor: 2.903

Review 5.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

Review 6.  A clinician's guide to cost-effectiveness analysis.

Authors:  A S Detsky; I G Naglie
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

7.  Economic evaluation of neonatal intensive care of very-low-birth-weight infants.

Authors:  M H Boyle; G W Torrance; J C Sinclair; S P Horwood
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

Review 8.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

9.  Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients.

Authors:  S Harkonen; P Scannon; R P Mischak; L E Spitler; C Foxall; D Kennedy; R Greenberg
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

10.  Impact of epoetin beta on dialyzer clearance and heparin requirements.

Authors:  B S Spinowitz; J Arslanian; C Charytan; R A Golden; J Rascoff; M Galler
Journal:  Am J Kidney Dis       Date:  1991-12       Impact factor: 8.860
View more
  1 in total

1.  Therapeutic dilemmas. An approach to the management of expensive pharmaceutical advances.

Authors:  L Y Nishimura; R Shane
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.